# Rubicon Research Limited (RUBICON)

> RUBICON closed at ₹1,610.50 on 30 Oct 2026, trailing P/E 92.4, market cap ₹26,634 cr, latest results for the quarter ended 30 Jun 2026. Revenue, profit, ROE, debt, own P/E range and sector-peer comparison from the SEBI filing.

Rubicon Research Limited (NSE: RUBICON) closed at ₹1,610.50 on 30 Oct 2026, +160.3% over one year, against a 52-week range of ₹570.75 – ₹1,899.00.

In the quarter ended 30 Jun 2026 (consolidated, filed 14 Aug 2026) it reported revenue of ₹534 cr and net profit of ₹85 cr, a 15.9% net margin.

On four consecutive filed quarters its trailing P/E is 92.4.

From the balance sheet dated 31 Mar 2026: return on equity 26.3%, ROCE 32.1%, debt-to-equity 0.20.

Against 65 Healthcare peers on NSE: Net margin higher than 59% of 63 sector peers; PBT margin higher than 60% of 63 sector peers; ROE higher than 89% of 63 sector peers.

## Key figures

| Figure | Value |
|---|---|
| Last close | ₹1,610.50 (30 Oct 2026) |
| Change 1 month / 6 months / 1 year | -3.9% / +71.6% / +160.3% |
| 52-week low – high | ₹570.75 – ₹1,899.00 |
| Market capitalisation | ₹26,634 cr |
| Trailing P/E | 92.4 |
| Price / book | 20.67 |
| EV / EBITDA | 57.7 |
| Earnings yield | 1.1% |
| TTM EPS | ₹17.43 |
| TTM net profit | ₹288 cr |
| Quarter revenue | ₹534 cr |
| Quarter net profit | ₹85 cr |
| Net margin | 15.9% |
| Return on equity | 26.3% |
| ROCE | 32.1% |
| Debt / equity | 0.20 |
| Current ratio | 2.01 |
| Free cash flow | ₹-24 cr |
| Average daily turnover (50 days) | ₹36.7 cr |

## Questions

### What is the P/E ratio of Rubicon Research Limited?

Rubicon Research Limited's trailing P/E is 92.4, using the close of 30 Oct 2026 and earnings over the four filed quarters to 30 Jun 2026.

### What were Rubicon Research Limited's latest quarterly results?

For the quarter ended 30 Jun 2026, Rubicon Research Limited reported revenue of ₹534 cr and net profit of ₹85 cr (consolidated), filed with the exchange on 14 Aug 2026.

### What is Rubicon Research Limited's ROE?

Return on equity is 26.3% based on the balance sheet dated 31 Mar 2026.

### Does Rubicon Research Limited have debt?

Debt-to-equity is 0.20 on the balance sheet dated 31 Mar 2026.

### What is RUBICON's 52-week high and low?

Over the last 52 weeks to 30 Oct 2026, RUBICON traded between ₹570.75 and ₹1,899.00.

Sector: [Healthcare](https://trinetra.trade/sectors/healthcare) · Page: https://trinetra.trade/fundamentals/RUBICON

_TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing._